NCT06695000

Brief Summary

This study evaluates the effectiveness and safety of a digital Cognitive Behavioral Therapy program for Insomnia (CBT-I) in individuals with chronic insomnia. Participants will be randomly assigned to either begin digital CBT-I immediately or join a wait-list.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

5 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 13, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 19, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

10 months

First QC Date

November 13, 2024

Last Update Submit

November 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Insomnia Severity Index (ISI) Score at Post-Intervention

    The Insomnia Severity Index (ISI) measures the severity of insomnia symptoms, with scores ranging from 0 to 28. Higher scores indicate more severe insomnia, with 0-7 representing no clinically significant insomnia, 8-14 mild insomnia, 15-21 moderate insomnia, and 22-28 severe insomnia. This outcome measures the change in ISI score from baseline to 6 weeks, comparing changes between the digital CBT-I group and the waitlist control group.

    "From baseline (Visit 1) to post-intervention assessment at 6 weeks

Secondary Outcomes (10)

  • Change from Baseline in Dysfunctional Beliefs and Attitudes about Sleep (DBAS-16) Score at Post-Intervention (6 Weeks)

    From baseline to 6 weeks post-intervention

  • Change from Baseline in Epworth Sleepiness Scale (ESS) Score at Post-Intervention (6 Weeks)

    From baseline to 6 weeks post-intervention

  • Change from Baseline in Patient Health Questionnaire-9 (PHQ-9) Score at Post-Intervention (6 Weeks)

    From baseline to 6 weeks post-intervention

  • Change from Baseline in Generalized Anxiety Disorder-7 (GAD-7) Score at Post-Intervention (6 Weeks)

    From baseline to 6 weeks post-intervention

  • Change from Baseline in Quality of Life (SF-36) Score at Post-Intervention (6 Weeks)

    From baseline to 6 weeks post-intervention

  • +5 more secondary outcomes

Other Outcomes (1)

  • System Usability Scale (SUS) Score for Digital CBT-I at Post-Intervention (6 Weeks)

    6 weeks post-intervention

Study Arms (2)

digital CBT-I

EXPERIMENTAL
Device: digital CBT-I

Waitlist Control

NO INTERVENTION

Interventions

The intervention is a digital Cognitive Behavioral Therapy for Insomnia (CBT-I) program, delivered via a mobile application. The program includes structured, self-guided modules focusing on sleep hygiene education, cognitive restructuring, stimulus control, bed time restriction, and relaxation techniques. Each module offers interactive exercises and weekly assignments designed to support behavior change and improve sleep. Participants will receive app-based reminders to encourage regular engagement, with features for tracking progress and adherence throughout the 6 week program.

Also known as: digital cognitive behavioral therapy for insomnia, SleepQ
digital CBT-I

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meets diagnostic criteria for insomnia disorder according to the International Classification of Diseases, 10th Revision (ICD-10), including: F51: Nonorganic sleep disorders; G47: Sleep disorders
  • Has experienced insomnia symptoms for 3 months or longer.
  • Scores 8 or higher on the Insomnia Severity Index (ISI).
  • Oral and written fluency in Korean
  • Owns a smartphone and is independently able to use apps on a smartphone.
  • Voluntarily agrees to participate in this clinical study and provides signed informed consent.

You may not qualify if:

  • Currently receiving non-pharmacological treatments for insomnia (e.g., CBT-I, light therapy, traditional medicine for sleep) within the past 3 months from screening.
  • Diagnosed with other sleep disorders aside from insomnia and currently symptomatic, such as:
  • Obstructive sleep apnea (G47.30)
  • Sleep behavior disorders
  • Restless leg syndrome (G28.8)
  • Narcolepsy (G47.4)
  • Has an active, ongoing physical illness that impedes daily functioning, such as:
  • Congestive heart failure
  • Chronic obstructive pulmonary disease (COPD)
  • Acute pain
  • Neurological disorders (e.g., cerebrovascular disease)
  • Neurodegenerative disorders (e.g., dementia, multiple sclerosis)
  • Unstable medical conditions or life expectancy of less than 6 months
  • Adjustments in schedule or dosage of sleep medications, antidepressants, anticonvulsants, anxiolytics, or antipsychotics within the past 3 months, or use of PRN (as needed) prescribed sleep medications.
  • Engaged in shift work.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Inje University Ilsan Paik Hospital

Goyang-si, Gyeonggi-do, 10380, South Korea

Location

Yongin Severance Hospital

Yongin-si, Gyeonggi-do, 16995, South Korea

Location

Severance Hospital, Yonsei University Health System

Seoul, Seoul, 03722, South Korea

Location

The Catholic University of Korea, Seoul ST. Mary's Hospital

Seoul, Seoul, 06591, South Korea

Location

Ewha Womans University Medical Center

Seoul, Seoul, 07804, South Korea

Location

Related Publications (1)

  • Moon DU, Kim J, Sun JH, Lee Y. Applying a mobile intervention for chronic insomnia in routine care: Study protocol for a multicenter randomized controlled trial. Internet Interv. 2025 Jun 20;41:100848. doi: 10.1016/j.invent.2025.100848. eCollection 2025 Sep.

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Central Study Contacts

Yujin Lee, Chief Medical Officer, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 13, 2024

First Posted

November 19, 2024

Study Start

January 1, 2025

Primary Completion

November 1, 2025

Study Completion

March 1, 2026

Last Updated

November 19, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations